| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chair &CEO | Director
2 companies
Galbraith Kenneth is a Chair &CEO at Zymeworks Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $6.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | Chair &CEO | Sale+OE | 30,424 | $22.67 | $689,818.56 | -11.8% | +13.6% | - | |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Chair &CEO | Sale+OE | 54,343 | $25.10 | $1,363,840.84 | -13.4% | +1.4% | - | |
| Dec 22, 2025 | ZYME Zymeworks Inc. | Chair &CEO | Sale+OE | 47,528 | $27.02 | $1,284,311.12 | -26.3% | -13.0% | - | |
| Jan 6, 2025 | ZYME Zymeworks Inc. | Chair &CEO | Sale+OE | 57,291 | $14.92 | $855,016.61 | -30.9% | -27.9% | +67.2% | |
| Jan 8, 2024 | ZYME Zymeworks Inc. | Chair &CEO | Sale+OE | 23,904 | $10.79 | $257,844.95 | -31.0% | -16.6% | +24.0% | |
| Sep 9, 2020 | MGNX MacRogenics Inc | Director | Sale+OE | 20,773 | $27.11 | $563,156.03 | -100% | - | - |